Niraparib + Dostarlimab + RT in Pancreatic Cancer

Conditions:   Pancreatic Cancer;   Metastatic Pancreatic Cancer Interventions:   Drug: Niraparib;   Drug: Dostarlimab;   Radiation: Radiation Sponsors:   Massachusetts General Hospital;   Tesaro, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials